One of the UK’s top manufacturing exporters has criticised the Government for making the full transition to Brexit unnecessarily complex. The chemical and pharmaceutical industry, whose wider activities (manufacturing plus distribution) is the largest exporter of manufactured goods with annual exports of close to £50 billion, has questioned the value of an interim customs union.
Azelis has reinforced ties with Tagra Biotechnologies and its position in Asia Pacific with an exclusive distribution agreement in China. Azelis has been appointed as exclusive distributor by Tagra Biotechnologies to offer their range of RND microencapsulated actives and pigments in China for all Personal Care applications. This new partnership builds on agreements between the two companies in Europe, Canada, Australia and New Zealand, and will reinforce Azelis’s position in Asia Pacific as a leading distributor of speciality chemicals.
Olon a leading CDMO and generics supplier headquartered in Italy, has acquired Ricerca Biosciences’ Chemical Division in Ohio, USA. The acquisition strengthens Olon’s service offering in North America, and benefits Ricerca Biosciences by providing large scale manufacturing capabilities in Europe. Olon has acquired Ricerca Biosciences’ Chemical Division based in Concord, Ohio, USA. Ricerca Biosciences is a US‐based CRO supporting the development and manufacture of APIs and performance materials in support clinical supply, market development and commercial distribution. Ricerca’s extensive process/synthetic chemistry, analytical chemistry and engineering expertise provides a synergy that excels at first‐time scale‐ups and subsequent development of safe, reliable, robust and cost-effective manufacturing processes.
A new Chemical Service Company has been formed – WeylChem InnoTec is the “Technology and Innovation backbone of WeylChem Group of Companies”.
CordenPharma is investing €10 million in a new manufacturing line for veterinary drug products in CordenPharma Plankstadt, near Heidelberg in Germany. CordenPharma Plankstadt are experts in the development and manufacturing of solid dosage forms, specializing in the safe handling of highly potent APIs and drug products, with a full range of services from pharmaceutical development for phase I to III to commercial-scale manufacturing, packaging and pharma-logistics (CEE-hub).